Ameriprise
GENE

Ameriprise’s Genetic Technologies Ltd. GENE Stock Holding History

Ameriprise’s Portfolio GENE Stock Details GENE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-229
Closed -$9K – 3951
2014
Q4 		$9K Buy
229
+82
+56% +$3.29K ﹤0.01% 3681
2014
Q3 		$8K Buy
147
+145
+7,250% +$11.3K ﹤0.01% 4960
2014
Q2 		$0 Buy
+2
New +$239 ﹤0.01% 5674
2014
Q1 		– Hold
0
– – – 5418
2013
Q4 		– Hold
0
– – – 5454
2013
Q3 		– Hold
0
– – – 5690
2013
Q2 		– Hold
0
– – – 5585

Other funds holding GENE

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return

Ameriprise's GENE Position: Q1 2015 in Review

Ameriprise sold out of Genetic Technologies Ltd. (GENE) in Q1 2015, closing a stake of 229 shares — an estimated $9K sold.

Ameriprise first reported a position in GENE in Q2 2014 and held it in 3 quarters. The position peaked at $9K in Q4 2014. 13 funds tracked by Wall St. Rank hold GENE as of Q1 2015.

  • Ameriprise reported no remaining Genetic Technologies Ltd. position as of Q1 2015 after selling out during the quarter.
  • Ameriprise sold 229 Genetic Technologies Ltd. shares in Q1 2015, an estimated $9K.
  • Ameriprise first reported a position in Genetic Technologies Ltd. in Q2 2014 and held it in 3 quarters.
  • Ameriprise's Genetic Technologies Ltd. position peaked at $9K in Q4 2014.
  • 13 funds tracked by Wall St. Rank held Genetic Technologies Ltd. as of Q1 2015.

Based on Ameriprise's 13F filing for Q1 2015, filed 14 May 2015.